IOXILAN® INJECTION IS INDICATED FOR CEREBRAL ARTERIOGRAPHY, CORONARY ARTERIOGRAPHY AND LEFT VENTRICULOGRAPHY, VISCERAL ANGIOGRAPHY, AORTOGRAPHY, AND PERIPHERAL ARTERIOGRAPHY.
BY INTRAVENOUS ROUTE: IOXILAN® INJECTION (300 MGI/ML) AND IOXILAN® INJECTION (350 MGI/ML) ARE INDICATED FOR EXCRETORY UROGRAPHY AND CONTRAST ENHANCED COMPUTED TOMOGRAPHIC (CECT) IMAGING OF THE HEAD AND BODY.
INTRAARTERIAL PROCEDURES:
CORONARY ARTERIOGRAPHY AND LEFT VENTRICULOGRAPHY
IOXILAN® INJECTION (350 MGL/ML) IS INDICATED FOR INTRAARTERIAL INJECTION.
LEFT AND RIGHT CORONARY: 2ML TO 10ML (0.7 TO 3.5 GL)
LEFT VENTRICLE: 25 ML TO 50 ML (8.75 TO 17.5 GL). TOTAL DOSE FOR THE PROCEDURE SHOULD NOT USUALLY EXCEED 250 ML.
WHEN LARGE INDIVIDUAL VOLUMES ARE ADMINISTERED, AS IN VENTRICULOGRAPHY AND AORTOGRAPHY, IT IS RECOMMENDED THAT SUFFICIENT TIME BE PERMITTED TO ELAPSE BETWEEN EACH INJECTION TO ALLOW FOR SUBSIDENCE OF POSSIBLE HEMODYNAMIC DISTURBANCES.
AORTOGRAPHY AND SELECTIVE VISCERAL ARTERIOGRAPHY:
PERIPHERAL ARTERIOGRAPHY:
INJECTION RATES SHOULD BE APPROXIMATELY EQUAL TO FLOW RATE IN THE VESSEL BEING INJECTED. THE USUAL INDIVIDUAL INJECTION VOLUMES FOR VISUALIZATION OF VARIOUS PERIPHERAL ARTERIES ARE AS FOLLOWS:
AORTIC BIFURCATION FOR DISTAL RUNOFF: 45 ML TO 100 ML (26 TO 70 GL).
SUBCLAVIAN OR FEMORAL ARTERY: 10 ML TO 40 ML (4 TO 14GL) OF IOXILAN® INJECTION - 350 (350 MGL/ML)
TOTAL DOSE FOR THE PROCEDURE SHOULD NOT USUALLY EXCEED 250 ML. PULSATION SHOULD BE PRESENT IN THE ARTERY TO BE INJECTED.
CEREBRAL ARTERIOGRAPHY:
IOXILAN® INJECTION (300 MGL/ML) IS INDICATED FOR INTRAARTERIAL INJECTION IN THE RADIOGRAPHIC CONTRAST EVALUATION OF ARTERIAL LESIONS OF THE BRAIN. THE USUAL INDIVIDUAL VOLUMES PER INJECTION ARE 8 ML TO 12 ML (2.4 TO 3.6 GL) OF IOXILAN® INJECTION - 300 (300 MGL/ML). TOTAL DOSE FOR THE PROCEDURE SHOULD NOT USUALLY EXCEED 150 ML.
INTRAVENOUS PROCEDURES:
INTRAVENOUS EXCRETORY UROGRAPHY:
IOXILAN® INJECTION (300 MGL/ML OR 350 MGL/ML) IS INDICATED FOR INTRAVENOUS INJECTION FOR ROUTINE EXCRETORY UROGRAPHY. A VOLUME OF CONTRAST WHICH GIVES A DOSE OF APPROXIMATELY 250 TO 390 MGL/KG OF BODY WEIGHT IS RECOMMENDED AS SUITABLE FOR ADULTS WITH NORMAL RENAL FUNCTION. TOTAL DOSE FOR THE PROCEDURE SHOULD NOT USUALLY EXCEED 100 ML.
CONTRAST ENHANCED COMPUTED TOMOGRAPHY:
IOXILAN® INJECTION (300 MGL/ML OR 350 MGL/ML) IS INDICATED FOR INTRAVENOUS INJECTION FOR CONTRAST-ENHANCEMENT IN THE EVALUATION OF NEOPLASTIC AND NON-NEOPLASTIC LESIONS OF THE HEAD AND BODY (INTRA THORACIC, INTRA ABDOMINAL, AND RETRO PERITONEAL REGIONS).
CECT OF THE HEAD:
THE USUAL DOSE IS 100 ML TO 200 ML (30 TO 60 GL) OF IOXILAN® INJECTION (300 MGL/ML) OR 86 ML TO 172 MLOF IOXILAN® INJECTION (350 MGL/ML). SCANNING MAY BE PERFORMED IMMEDIATELY AFTER COMPLETION OF THE INTRAVENOUS ADMINISTRATION.
TOTAL DOSE FOR THE PROCEDURE SHOULD NOT USUALLY EXCEED 200 ML.
CECT OF THE BODY:
IOXILAN® INJECTION (300 MGL/ML OR 350 MGL/ML) MAY BE ADMINISTERED INTRAVENOUSLY BY BOLUS, BY RAPID INFUSION, OR BY A COMBINATION OF BOTH. THE USUAL DOSE IS 50 ML TO 200 ML (15 TO 60 GL) OF IOXILAN® (300 MGL/ML) OR 43 ML TO172 ML OF IOXILAN® (350 MGL/ML). TOTAL DOSE FOR THE PROCEDURE SHOULD NOT USUALLY EXCEED 200 ML.